Harmony Biosciences Holdings Inc (NASDAQ: HRMY) is -17.29% lower on its value in year-to-date trading and has touched a low of $26.47 and a high of $41.61 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HRMY stock was last observed hovering at around $27.94 in the last trading session, with the day’s gains setting it 0.52%.
Currently trading at $28.46, the stock is -8.06% and -14.97% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.46 million and changing 1.86% at the moment leaves the stock -18.11% off its SMA200. HRMY registered -4.43% loss for a year compared to 6-month loss of -19.83%. The firm has a 50-day simple moving average (SMA 50) of $33.4687 and a 200-day simple moving average (SMA200) of $34.755627.
The stock witnessed a -17.27% gain in the last 1 month and extending the period to 3 months gives it a -26.15%, and is -1.83% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.46% over the week and 4.73% over the month.
Harmony Biosciences Holdings Inc (HRMY) has around 268 employees, a market worth around $1.63B and $714.73M in sales. Current P/E ratio is 11.34 and Fwd P/E is 7.03. Profit margin for the company is 20.36%. Distance from 52-week low is 7.52% and -31.60% from its 52-week high. The company has generated returns on investments over the last 12 months (17.68%).
with sales reaching $184.26M over the same period.The EPS is expected to grow by 25.17% this year, but quarterly earnings will post 17.82% year-over-year. Quarterly sales are estimated to grow 19.17% in year-over-year returns.
365.0 institutions hold shares in Harmony Biosciences Holdings Inc (HRMY), with institutional investors hold 110.96% of the company’s shares. The shares outstanding are 57.14M, and float is at 43.54M with Short Float at 8.02%. Institutions hold 98.08% of the Float.
The top institutional shareholder in the company is VALOR MANAGEMENT LLC with over 11.22 million shares valued at $338.45 million. The investor’s holdings represent 19.7492 of the HRMY Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.84 million shares valued at $176.05 million to account for 10.2729 of the shares outstanding. The other top investors are FMR LLC which holds 5.24 million shares representing 9.2213 and valued at over $158.03 million, while VANGUARD GROUP INC holds 6.1992 of the shares totaling 3.52 million with a market value of $106.18 million.
Harmony Biosciences Holdings Inc (HRMY) Insider Activity
The most recent transaction is an insider sale by Kapadia Sandip, the company’s CHIEF FINANCIAL OFFICER. SEC filings show that Kapadia Sandip sold 6,987 shares of the company’s common stock on Apr 01 ’25 at a price of $32.54 per share for a total of $0.23 million. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Mar 03 ’25, Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) disposed off 4,869 shares at an average price of $32.67 for $0.16 million. The insider now directly holds 0 shares of Harmony Biosciences Holdings Inc (HRMY).
